Clinical editor of WOUNDS presenting for COV!COV.v: Today's PR might not strike you as a big deal, it doesn't look like much more than another conference appearance, but when I Google'd the name of the guy hosting the Symposium, I am once again impressed that we have a company with leading edge technologies, trading at a huge discount to it's more respected "peers" in the industry. Dr. Terry Treadwell is no slouch, he is the Clinical Editor of the WOUNDS Journal, the most widely read journal focussing on wound care. https://www.woundsresearch.com/content/editorial-board WOUNDS is the most widely read, peer-reviewed journal focusing on wound care and wound research. The information disseminated to our readers includes valuable research and commentaries on tissue repair and regeneration, biology and biochemistry of wound healing, and clinical management of various wound etiologies. I take it as a very positive sign that a guy that is chief editor for the leading wound care journal is presenting on our behalf. I maintain my position that this is a high quality, undiscovered name in this industry that deserves a valuation similar to that of DSCI, ALQA, MDWD, etc.. Someone has sold off this stock again the past few days, I think they created I nice entry opportunity in the short term. The company just began scheduling earnings calls last quarter.....I don't think they did this to discuss lackluster results....we know the middle East tenders present big opportunities.....I do think this could be a break out year ahead for the company.....can't wait to see results at month end!